Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT04479267
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-29
First Post:
2020-07-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-19
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-16
First Submit QC Date:
None
Study First Post Date:
2020-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-09-29
Last Update Post Date Type:
ESTIMATED